Cargando…

TWEAK Signaling‐Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis

The malignant transformation of hepatic progenitor cells (HPCs) in the inflammatory microenvironment is the root cause of hepatocarcinogenesis. However, the potential molecular mechanisms are still elusive. The HPCs subgroup is identified by single‐cell RNA (scRNA) sequencing and the phenotype of HP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenting, Gao, Lu, Hou, Xiaojuan, Feng, Shiyao, Yan, Haixin, Pan, Hongyu, Zhang, Shichao, Yang, Xue, Jiang, Jinghua, Ye, Fei, Zhao, Qiudong, Wei, Lixin, Han, Zhipeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288241/ https://www.ncbi.nlm.nih.gov/pubmed/37085918 http://dx.doi.org/10.1002/advs.202300350

Ejemplares similares

AIF1(+)CSF1R(+) MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis
por: Zong, Chen, et al.
Publicado: (2023)

Babao Dan decreases hepatocarcinogenesis by inhibiting hepatic progenitor cells malignant transformation via down-regulating toll-like receptor 4
por: Liang, Lei, et al.
Publicado: (2023)

TWEAKing death
por: Ashwell, Jonathan D.
Publicado: (2008)

The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020)

Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis
por: Czauderna, Carolin, et al.
Publicado: (2021)

Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2022)

Tweaking Microtubules to Treat Scleroderma
por: van Laar, Jacob M, et al.
Publicado: (2005)

Disuse TWEAKs muscle loss
por: Short, Ben
Publicado: (2010)

The “tweaking principle” for task switching
por: Ardid, Salva, et al.
Publicado: (2014)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
por: Iacobas, Dumitru A., et al.
Publicado: (2021)

Macrophages and hepatocellular carcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2019)

Extracellular microparticles derived from hepatic progenitor cells deliver a death signal to hepatoma-initiating cells
por: Hou, Xiaojuan, et al.
Publicado: (2022)

Loss of TP53 cooperates with c-MET overexpression to drive hepatocarcinogenesis
por: Zhou, Yi, et al.
Publicado: (2023)

The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation
por: Shao, Changchun, et al.
Publicado: (2021)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

The Role of Ubiquitination in TWEAK-Stimulated Signaling
por: Vucic, Domagoj
Publicado: (2013)

TWEAK Negatively Regulates Human Dicer
por: Lambert, Marine, et al.
Publicado: (2016)

TWEAK Progress in Dermatology: A Review
por: Kharel, Pramisha, et al.
Publicado: (2023)

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
por: Chicheportiche, Yves, et al.
Publicado: (2002)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

ID1 and CEBPA coordinate epidermal progenitor cell differentiation
por: Kantzer, Christina Geraldine, et al.
Publicado: (2022)

A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells: a systematic review
por: Wang, Sijia, et al.
Publicado: (2022)

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
por: Chao, Debra T., et al.
Publicado: (2012)

Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
por: Fabregat, Isabel, et al.
Publicado: (2018)

Capsaicin suppresses hepatocarcinogenesis by inhibiting the stemness of hepatic progenitor cells via SIRT1/SOX2 signaling pathway
por: Xie, Zhi‐Qin, et al.
Publicado: (2022)

TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009)

TWEAK: A New Player in Obesity and Diabetes
por: Vendrell, Joan, et al.
Publicado: (2013)

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
por: Terryn, Joke, et al.
Publicado: (2021)

Tweaking the catalytic efficiency of the CFTR ion channel
por: McCarty, Nael A.
Publicado: (2023)

GLUTATHIONE S‐TRANSFERASES AND HEPATOCARCINOGENESIS
por: Sato, Kiyomi
Publicado: (1988)

Oxidative stress and hepatocarcinogenesis
por: Fu, Ying, et al.
Publicado: (2018)

Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
por: Bogaerts, Eliene, et al.
Publicado: (2016)

Dysregulation of Bmi1 promotes malignant transformation of hepatic progenitor cells
por: Zhang, R, et al.
Publicado: (2016)

The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity
por: Zhao, Shanmin, et al.
Publicado: (2020)

Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
por: Kurahashi, Tomohide, et al.
Publicado: (2019)

Involvement of Tweak in Interferon γ–Stimulated Monocyte Cytotoxicity
por: Nakayama, Masafumi, et al.
Publicado: (2000)

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
por: Bertin, Daniel, et al.
Publicado: (2013)

TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
por: Sidler, Daniel, et al.
Publicado: (2017)

TWEAK/Fn14 Activation Participates in Skin Inflammation
por: Liu, Qilu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6nca7vhishiflkol8gbif2e7ct